|

Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for Dynamic Decision-Making

RECRUITINGSponsored by Shanghai Zhongshan Hospital
Actively Recruiting
SponsorShanghai Zhongshan Hospital
Started2026-07-21
Est. completion2027-08-31
Eligibility
Age55 Years+
SexMALE
Healthy vol.Accepted

Summary

Development of an Intelligent System Integrating Preoperative Imaging and Real-Time Intraoperative Metabolic Feedback to Dynamically Optimize Biopsy core Placement for Individualized Precision Sampling.

Eligibility

Age: 55 Years+Sex: MALEHealthy volunteers accepted
Inclusion Criteria:

1. Age ≥55 years;
2. Indication for prostate biopsy;
3. Availability of total prostate-specific antigen (tPSA), free PSA (fPSA) levels, and multiparametric MRI (mpMRI) results within 1 month prior to biopsy.

Exclusion Criteria:

1. Pathological diagnosis of malignancies other than prostatic acinar adenocarcinoma;
2. Concomitant malignant tumors potentially affecting imaging findings (e.g., rectal, bladder, or testicular cancer);
3. Cachexia or organ function decompensation.

Conditions3

CancerProstate Cancer (Adenocarcinoma)Prostate Cancer (Diagnosis)

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.